DALLAS--(BUSINESS WIRE)--OncoNano Medicine, Inc. ("OncoNano†) today announced a research collaboration with Gilead Sciences, Inc. (Nasdaq: GILD) ("Gilead†) to evaluate OncoNano's ON- BOARDâ"¢ encapsulation technology with Gilead's drug candidate. Under the terms of the agreement, OncoNano and Gilead will collaborate to evaluate the stability, selectivity and efficacy of Gilead's drug candidate encapsulated by OncoNano's ON-BOARD technology. "Partnering with Gilead underscores the broad applicabili. ...